Polygenic and multifactorial disease gene association in man: Lessons from AIDS

Annual Review of Genetics

Volumn 34, Issue , 2000, Pages 563-591

  O'Brien, S J ^a   Nelson, G W ^a   Winkler, C A ^a   Smith, M W ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

AIDS; Complex traits; Restriction gene; SNP

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; INTERLEUKIN 10;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MULTIFACTORIAL INHERITANCE; PRIORITY JOURNAL; RESTRICTION SITE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALLELES; EPIDEMIOLOGY, MOLECULAR; GENES, DOMINANT; GENES, RECESSIVE; HUMANS; PHENOTYPE; SURVIVAL ANALYSIS;

AIDS VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034505149     PISSN: 00664197     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genet.34.1.563     Document Type: Review

References (129)

1. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
2. Freely associating
3. Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1
4. Homozygous Δ32 deletion of the CCR-5 chemokine receptor gene in an HIV-1 infected patient
5. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by CCR5Δ32
6. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
7. HIV-1 infection in an individual homozygous for the CCR5 deletion allele
8. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
9. CCR5 promoter alleles distinguished by specific DNA binding factors
10. Linkage disequilibrium in admixed populations: Applications in gene mapping
11. Long-term HIV-1 infection without immunologic progression
12. Characterization of single-nucleotide polymorphisms in coding regions of human genes
13. Genetics of HIV-1 infection: Chemokine receptor CCR5 polymorphism and its consequences
14. HLA and HIV-1: Heterozygote advantage and B* 35-Cw*04 disadvantage
15. Admixture as a tool for finding linked genes and detecting the difference from allelic association between loci
16. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
17. Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells
18. Pathogenesis and medical aspects of HIV-1 infection
19. Genetic epidemiology of single-nucleotide polymorphisms
20. Variations on a theme: Cataloging human DNA sequence variation
21. New goals for the U.S. Human Genome Project: 1998-2003
22. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
23. Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-Δ32 mutation
24. A physical map of 30,000 human genes
25. Identification of a major co-receptor for primary isolates of HIV-1
26. For the Multicenter AIDS Cohort Study: Resistance to HIV-1 infection
27. A comprehensive genetic map of the human genome based on 5,264 microsatellites
28. Progression to AIDS
29. A dual-tropic primary HIV-1 isolate that uses fusin and the betachemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
30. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
31. Chemokines and HIV-1 second receptors-confluence of two fields generates optimism in AIDS research
32. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-1 seropositive individuals
33. Pharmacogenomics: Translating functional genomics into rational therapeutics
34. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
35. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
36. IL10 inhibits cytokine production by activated macrophages
37. Applications for heteroduplex analysis for mutations detection in disease genes
38. Decreased helper T lymphocytes in homosexual men. I. Sexual contact in high-incidence areas for the acquired immunodeficiency syndrome
39. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia
40. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes
41. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis
42. Hemophilia growth and development study. Design, methods, and entry data
43. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
44. A simple sequentially rejective multiple test procedure
45. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
46. Natural selection at major histocompatibility complex loci of vertebrates
47. Association between CCR5 genotype and the clinical course of HIV-1 infection
48. A scan for linkage disequilibrium across the human genome
49. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis
50. The Multicenter AIDS Cohort Study: Rationale, organization, and selected characteristics of the participants
51. Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver
52. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation
53. Prospects for whole-genome linkage disequilibrium mapping of common disease genes
54. Mapping genes by drift-generated linkage disequilibrium in human populations
55. Genetic dissection of complex traits
56. Significant admixture linkage disequilibrium across 30 cM around the FY locus in African Americans
57. Human immunodeficiency virus (HIV) type 1 infection status and in vitro susceptibility to HIV infection among high-risk HIV-1-seronegative hemophiliacs
58. Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4
59. The occurrence of lung cancer in man
60. The ΔCCR5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe
61. High density synthetic oligonucleotide arrays
62. Chemokine receptors: Keys to AIDS pathogenesis?
63. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
64. Frequencies of the CC chemokine receptor 5 Δ32 allele in various populations of defined racial background
65. Multiple comparison procedures updated
66. CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function
67. Genetic acceleration of AIDS progression by a promoter variant of CCR5
68. Global distribution of the CCR5 gene 32-basepair deletion
69. As consortium plans free SNP map of human genome
70. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS)
71. Mapping genes that underlie ethnic differences in disease risk: Methods for detecting linkage in admixed populations, by conditioning on parental admixture
72. Host genes and HIV: The role of the chemokine receptor gene CCR5 and its allele (Δ32 CCR5)
73. Chemokine control of HIV-1 infection
74. Complete sequence and gene map of a human major histocompatibility complex
75. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression
76. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression
77. Proportion of disease caused or prevented by a given exposure, trait or intervention
78. Enhanced interleukin-10 production in response to Mycobacterium avium products in mononuclear cells from patients with human immunodeficiency virus infection
79. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression
80. Antigenic diversity thresholds and the development of AIDS
81. AIDS: A role for host genes
82. The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS
83. HIV-1 infection in a man homozygous for CCR5Δ32
84. Population biology of antigen presentation by MHC class I molecules
85. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: The Multicenter AIDS Cohort Study
86. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition
87. Detecting high-resolution polymorphisms in human coding loci by combining PCR and single-strand conformation polymorphism (SSCP) analysis
88. Chemokine receptors: Gateways to inflammation and infection
89. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma
90. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression
91. The future of genetic studies of complex human diseases
92. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection
93. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
94. Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production
95. Use of denaturing HPLC to map human and murine genes and to validate single-nucleotide polymorphisms
96. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations
97. Plots of P-values to evaluate many tests simultaneously
98. HIV-1 infection in individuals with the CCR5-Δ32/Δ32 genotype: Acquisition of syncytium inducing virus at seroconversion
99. Genetic restriction of HIV-1 infection and AIDS progression by promoter alleles of interleukin 10
100. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene
101. Rectangular confidence regions for the means of multivariate normal distributions
102. CCR2 chemokine receptor and AIDS progression
103. Contrasting genetic influence of CCR2 and CCR5 receptor gene variants on HIV-1 infection and disease progression
104. Progression to AIDS
105. Mapping by admixture linkage disequilibrium (MALD) in human populations: Limits and guidelines
106. Dating the origin of the CCR5-Δ32 AIDS resistance gene allele by the coalescence of haplotypes
107. Mapping genes through the use of linkage disequilibrium generated by genetic drift, "drift mapping" in small populations with no demographic expansion
108. HIV-1 infection in an individual homozygous for CCR5-Δ32
109. Detection of numerous Y chromosome biallelic polymorphisms by denaturing high performance liquid chromatography
110. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drag users: Description of methods and characteristics of participants
111. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome
112. Viral dynamics in human immunodeficiency virus type 1 infection
113. The Human Genome Project: From mapping to sequencing
114. Mining the genome for drugs
115. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant
116. Population choice in mapping genes for complex diseases
117. CCR5 levels and expression pattern correlate with infectibility by macrophage-tropic HIV-1, in vitro
118. Genetic structure of five susceptibility gene regions for coronary artery disease: Disequilibria within and among regions
119. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection
120. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection
121. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk